BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28969624)

  • 1. Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making.
    Thompson JJ; Ritenbaugh C; Nichter M
    BMC Womens Health; 2017 Oct; 17(1):97. PubMed ID: 28969624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concerns About Compounded Bioidentical Menopausal Hormone Therapy.
    Pinkerton JV
    Cancer J; 2022 May-Jun 01; 28(3):241-245. PubMed ID: 35594471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounded bioidentical menopausal hormone therapy - a physician perspective.
    Stuenkel CA
    Climacteric; 2021 Feb; 24(1):11-18. PubMed ID: 33073628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compounded bioidentical menopausal hormone therapy.
    ;
    Fertil Steril; 2012 Aug; 98(2):308-12. PubMed ID: 22831824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bioidentical compounded hormones for menopausal concerns: cross-sectional survey in an academic menopause center.
    Iftikhar S; Shuster LT; Johnson RE; Jenkins SM; Wahner-Roedler DL
    J Womens Health (Larchmt); 2011 Apr; 20(4):559-65. PubMed ID: 21486160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compounded Bioidentical Menopausal Hormone Therapy: ACOG Clinical Consensus No. 6.
    Obstet Gynecol; 2023 Nov; 142(5):1266-1273. PubMed ID: 37856860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.
    McBane SE; Borgelt LM; Barnes KN; Westberg SM; Lodise NM; Stassinos M
    Pharmacotherapy; 2014; 34(4):410-23. PubMed ID: 24390902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of compounded bioidentical hormone therapy (cBHT) in perimenopausal and postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Liu Y; Yuan Y; Day AJ; Zhang W; John P; Ng DJ; Banov D
    Menopause; 2022 Feb; 29(4):465-482. PubMed ID: 35357369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spotlight on Compounded Bioidentical Hormones.
    Santangelo G; Lagana AS; Giannini A; Murina F; Di Dio C; Ruggiero G; Di Donato V; Perniola G; Fischetti M; Casorelli A; Clemente F; Minnetti M; Lombardo F; Benedetti Panici P; Muzii L; Bogani G
    Gynecol Obstet Invest; 2024; 89(1):31-40. PubMed ID: 38151014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fear, misinformation, and pharmaceutical messianism in the promotion of compounded bioidentical hormone therapy.
    Kauffman RP; MacLaughlin EJ; Courtney LA; Vineyard DD
    Front Reprod Health; 2024; 6():1378644. PubMed ID: 38486847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3.
    Deleruyelle LJ
    Int J Pharm Compd; 2017; 21(1):6-16. PubMed ID: 28346192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(6):447-454. PubMed ID: 28339382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre.
    Natari RB; Hollingworth SA; Clavarino AM; Dingle KD; McGuire TM
    BMC Womens Health; 2021 Oct; 21(1):348. PubMed ID: 34607596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on counseling patients about menopausal hormone therapy: strategies in a complex data environment.
    Parish SJ; Nappi RE; Kingsberg S
    Menopause; 2018 Aug; 25(8):937-949. PubMed ID: 29509600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ethical assessment of compounded bioidentical hormone therapy.
    Kauffman RP; MacLaughlin EJ; Courtney LA; Vineyard DD
    Climacteric; 2024 Jun; 27(3):326-328. PubMed ID: 38288691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioidentical hormones.
    Stanczyk FZ; Matharu H; Winer SA
    Climacteric; 2021 Feb; 24(1):38-45. PubMed ID: 33403887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioidentical hormones for menopausal therapy.
    Sites CK
    Womens Health (Lond); 2008 Mar; 4(2):163-71. PubMed ID: 19072518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of compounded bioidentical hormone replacement therapy: an observational cohort study.
    Ruiz AD; Daniels KR; Barner JC; Carson JJ; Frei CR
    BMC Womens Health; 2011 Jun; 11():27. PubMed ID: 21651797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.